BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7354137)

  • 1. Stereoselective interaction of phenylbutazone with [12C/13C]warfarin pseudoracemates in man.
    O'Reilly RA; Trager WF; Motley CH; Howald W
    J Clin Invest; 1980 Mar; 65(3):746-53. PubMed ID: 7354137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of secobarbital with warfarin pseudoracemates.
    O'Reilly RA; Trager WF; Motley CH; Howald W
    Clin Pharmacol Ther; 1980 Aug; 28(2):187-95. PubMed ID: 7398186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative interaction of sulfinpyrazone and phenylbutazone with racemic warfarin: alteration in vivo of free fraction of plasma warfarin.
    O'Reilly RA; Goulart DA
    J Pharmacol Exp Ther; 1981 Dec; 219(3):691-4. PubMed ID: 7299692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The stereoselective interaction of warfarin and metronidazole in man.
    O'Reilly RA
    N Engl J Med; 1976 Aug; 295(7):354-7. PubMed ID: 934223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylbutazone and sulfinpyrazone interaction with oral anticoagulant phenprocoumon.
    O'Reilly RA
    Arch Intern Med; 1982 Sep; 142(9):1634-7. PubMed ID: 7114982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.
    Lewis RJ; Trager WF; Chan KK; Breckenridge A; Orme M; Roland M; Schary W
    J Clin Invest; 1974 Jun; 53(6):1607-17. PubMed ID: 4830225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warfarin-phenylbutazone interaction in man: a long term multiple dose study.
    Schary WL; Lewis RJ; Rowland M
    Res Commun Chem Pathol Pharmacol; 1975 Apr; 10(4):663-72. PubMed ID: 1153844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative interaction of cimetidine and ranitidine with racemic warfarin in man.
    O'Reilly RA
    Arch Intern Med; 1984 May; 144(5):989-91. PubMed ID: 6324710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective interaction of sulfinpyrazone with racemic warfarin and its separated enantiomorphs in man.
    O'Reilly RA
    Circulation; 1982 Jan; 65(1):202-7. PubMed ID: 7053283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans.
    O'Reilly RA; Trager WF; Rettie AE; Goulart DA
    Clin Pharmacol Ther; 1987 Sep; 42(3):290-4. PubMed ID: 3621782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticrynafen-racemic warfarin interaction: hepatotoxic or stereoselective?
    O'Reilly RA
    Clin Pharmacol Ther; 1982 Sep; 32(3):356-61. PubMed ID: 7105625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The warfarin-sulfinpyrazone interaction: stereochemical considerations.
    Toon S; Low LK; Gibaldi M; Trager WF; O'Reilly RA; Motley CH; Goulart DA
    Clin Pharmacol Ther; 1986 Jan; 39(1):15-24. PubMed ID: 3943265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenylbutazone-warfarin interaction in the dog.
    Bachmann KA; Burkman AM
    J Pharm Pharmacol; 1975 Nov; 27(11):832-6. PubMed ID: 1491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations.
    Banfield C; O'Reilly R; Chan E; Rowland M
    Br J Clin Pharmacol; 1983 Dec; 16(6):669-75. PubMed ID: 6661352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racemic warfarin and trimethoprim-sulfamethoxazole interaction in humans.
    O'Reilly RA; Motley CH
    Ann Intern Med; 1979 Jul; 91(1):34-6. PubMed ID: 464451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effect of fortified wine ingested during fasting and anticoagulant therapy.
    O'Reilly RA
    Arch Intern Med; 1981 Mar; 141(4):458-9. PubMed ID: 7212888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of warfarin metabolism by diltiazem in humans.
    Abernethy DR; Kaminsky LS; Dickinson TH
    J Pharmacol Exp Ther; 1991 Apr; 257(1):411-5. PubMed ID: 2020000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of the warfarin-rifampin drug interaction in humans.
    Heimark LD; Gibaldi M; Trager WF; O'Reilly RA; Goulart DA
    Clin Pharmacol Ther; 1987 Oct; 42(4):388-94. PubMed ID: 3665337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clofibrate displaces warfarin from plasma proteins in man: an example of a pure displacement interaction.
    Bjornsson TD; Meffin PJ; Swezey S; Blaschke TF
    J Pharmacol Exp Ther; 1979 Sep; 210(3):316-21. PubMed ID: 480183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of feprazone and phenylbutazone interaction with warfarin in man.
    Chierichetti S; Bianchi G; Cerri B
    Curr Ther Res Clin Exp; 1975 Oct; 18(4):568-72. PubMed ID: 810317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.